This report was first published by Endpoints News. To see the original version, click here
Amid the chaos of George Tidmarsh’s sudden resignation on Sunday and short-lived plan to fight back, XYXYYX has quickly been named the acting director of the FDA’s Center for Drug Evaluation and Research.
Something about who he/she is and what the replacement means for the agency.
您已閱讀37%（370字），剩余63%（634字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。